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Abstract 26 
Stressor exposure activates the hypothalamic-pituitary-adrenal (HPA) axis and causes 27 
elevations in the levels of glucocorticoids (GC) from the adrenal glands. Increasing evidence 28 
has demonstrated that prolonged exposure to high GC levels can lead to oxidative stress, 29 
mitochondrial dysfunction and apoptosis in a number of cell types. However, melatonin, via 30 
its antioxidant activity, exhibits a neuroprotective effect against oxidative stress-induced cell 31 
death. Therefore, in the present study, we explored the protective effect of melatonin in GC-32 
induced toxicity in human neuroblastoma SH-SY5Y cells. Cellular treatment with the 33 
toxically high doses of the synthetic GC receptor agonist, dexamethasone (DEX) elicited 34 
marked decreases in the levels of glutathione and increases in ROS production, lipid 35 
peroxidation and cell death. DEX toxicity also induced increases in the levels of cytosolic 36 
calcium and mitochondrial fusion proteins. Mitochondrial damage was observed in large 37 
proportions of the DEX-treated cells. Pretreatment of the cells with melatonin substantially 38 
prevented the DEX-induced toxicity. These results suggest that melatonin might exert 39 
protective effects against oxidative stress, mitochondrial damage and cytosolic calcium 40 
overload in DEX-induced neurotoxicity.  41 
 42 
 43 
 44 
 45 
 46 
 47 
3 
 
1. Introduction 48 
Stressor exposure leads to the activation of the hypothalamic-pituitary-adrenal (HPA) 49 
axis and induces the secretion of the glucocorticoid stress hormones (GCs; cortisol in human, 50 
corticosterone (CORT) in rats), which exert widespread effects on many systems, including 51 
the brain [1]. In humans, stress-induced toxicity has been observed in many 52 
neurodegenerative diseases, including ischemic infarction [2]. Clinical investigations 53 
suggest that patients with Alzheimer’s disease (AD) and Parkinson’s disease (PD) exhibit 54 
higher total plasma cortisol concentrations [3]. Higher GCs levels lead to increases in reactive 55 
oxygen species (ROS) production that directly cause mitochondria dysfunction, decrease 56 
cellular energy yield, elevate cytosolic Ca2+ concentrations and alter mitochondrial 57 
permeability, which leads to apoptosis in neuron cells [4].  58 
Many studies have provided compelling evidence that mitochondrial dysfunction 59 
plays a causative role in neurodegeneration. It has been demonstrated that mitochondrial 60 
dysfunctions are caused by imbalances in the mitochondrial dynamics of fission and fusion. 61 
[5]. Mitochondrial fission events are required in dividing cells and are also important during 62 
differentiation and in response to new energy demands and toxin exposures. Mitochondrial 63 
fusion (the process opposing fission) plays important roles in development and cell biology 64 
and also plays a protective role in apoptosis [6].  65 
Melatonin is substance that, in the brain, is primarily synthesized and secreted by the 66 
pineal gland. In addition to its major role in circadian rhythm regulation, melatonin has been 67 
found to possess free radical scavenging properties and to effective in protecting cells from 68 
oxidative damage [7]. Previous studies have shown that melatonin can prevent oxidative 69 
stress-induced neuronal damage in dexamethasone (DEX)-treated SH-SY5Y cells [8]. Until 70 
recently, the exactly mechanisms by which stress and the GC stress hormone contribute to the 71 
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activation of cell death processes have remained unclear. Therefore, in the present study, we 72 
proposed a mechanism of the regulation of neuronal cell death by the synthetic GC receptor 73 
agonist DEX that is mediated via stress-induced cytosolic calcium overload and 74 
mitochondrial damage. Mitochondrial damage is dependent on imbalances in the dynamic 75 
mitochondrial processes of fission and fusion processes. Additionally, we also propose that 76 
melatonin has protective effects against GC-induced neurotoxicity.  77 
2. Material and methods 78 
2.1. Chemicals and Reagents 79 
Melatonin was obtained from Sigma Aldrich (St. Louis, MO, USA). Mouse 80 
monoclonal anti-actin was purchased from Chemicon International (Temecula, CA, USA). 81 
Mouse monoclonal anti-Fis1, anti-Drp1, anti-Mfn1 and anti-Opa1 were purchased from Santa 82 
Cruz Biotechnology, Inc. All other chemicals used in this study were analytical grade and 83 
obtained essentially either from Sigma Aldrich or Lab-Scan Analytical Science (Dublin, 84 
Ireland). 85 
2.2. Cell cultures 86 
Human neuroblastoma (SH-SY5Y) cells were maintained in 75-cm2 flasks with 87 
minimum essential medium (MEM)-F12, supplemented with 10% heat-inactivated fetal 88 
bovine serum (FBS) at 37 °C in an atmosphere of 5% CO2 and 95% air. For the experiments, 89 
the cells were seeded in 96-well and 6-well plates and grown to 70-80% confluence. Before 90 
the initiation of treatment, the media were replaced with MEM containing 1% (v/v) FBS.  91 
2.3. Reactive oxygen species (ROS) assay 92 
Cytosolic ROS production was measured by dihydroethidium (HEt) fluorescence. 93 
Fluorescence measurements were obtained with an epifluorescence inverted microscope 94 
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equipped with a 20x fluorite objective. HEt was monitored in single cells using excitation 95 
light provided by a Xenon arc lamp. All imaging data were collected and analyzed using the 96 
Kinetic Imaging (Wirral, UK) software. All presented data were obtained from at least five 97 
coverslips and three different cell preparations. 98 
2.4. Glutathione measurements 99 
The cells were incubated with 50 µM monochlorobimane (MCB) in HBSS at room 100 
temperature for 40 min or until a steady state had been reached before images were acquired 101 
for quantitation. The images of the fluorescence of the MCB_GSH adduct were acquired 102 
using either a cooled CCD imaging system with excitation at 380 nm and emission at > 400 103 
nm or a Zeiss UV-vis 510 CLSM with excitation at 351 nm and emission at 435-485 nm. 104 
2.5. Lipid peroxidation assay 105 
The cells were loaded with 5 µM C11-BODIPY (581/591) for 30 min. The C11-106 
BODIPY dye incorporates into the cytoplasmic membrane and responds to eventual lipid 107 
peroxidation by altering its fluorescence properties [17]. C11-BODIPY (581/591) was 108 
excited using the 488 nm and 543 nm laser lines, and fluorescence was measured using a 109 
bandpass filter of 505-550 nm and a 560-nm longpass filter. All data presented were obtained 110 
from four different cell preparations. 111 
2.6. Cytosolic calcium ([Ca2+]c) determination 112 
SH-SY5Y cells were loaded with 5 µM fluo-4 AM and 0.005% pluronic in a HBSS 113 
for 30 min at room temperature, [Ca2+]c was then measured. The fluo-4 signal was excited at 114 
490 nm and measured above 515 nm. Cytosolic calcium was measured under an FV10i 115 
confocal microscope (Olympus, Bio Imaging Center, Thailand).  116 
2.7. Western immunoblotting 117 
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The cells were grown to the subconfluent stage in six-well plates. The cells were 118 
lysed by the addition of lysis buffer and scraped off the plate. The cells were sonicated for 10 119 
s and centrifuged for 15 min at 12,000 g. The supernatants were collected and subjected to 120 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The protein bands 121 
were transferred to nitrocellulose membranes. The membranes were incubated in blocking 122 
buffer (5% non-fat dry milk in TBST), and then incubated in the primary antibodies at 4ºC 123 
overnight. The membranes were incubated in HRP-conjugated secondary antibody for 1.30 124 
hr. The blots were developed with Chemiluminescent ECL Plus Western Blotting detection 125 
reagents. 126 
2.8. Cytotoxicity assay 127 
The cells were exposed to 5 µM propidium iodide (PI), which exhibits a red 128 
fluorescence. PI is excluded from viable cells and thus stains cells that have lost their 129 
membrane integrity. Some cells were exposed to 5 µM Hoechst 33342, which stains 130 
chromatin blue, to count the total numbers of cells. This process allowed us to express of the 131 
number of dead (red-stained) cells as a fraction of the total number of nuclei that were 132 
counted. Total numbers of 100-300 SH-SY5Y cells were counted in 4-5 fields of each 133 
coverslip. Each experiment was repeated four or more times using separate cultures. 134 
2.9. Transmission electron microscopy (TEM) 135 
The SH-SY5Y cells were grown in 75-cm2 culture flask. The cells were fixed with 136 
ice-cold 4% phosphate-buffered glutaraldehyde for 30-60 min. The fixed cell cultures were 137 
then rinsed three times for 10 min each with 0.1 M PBS. The cells were post-fixed with 2% 138 
phosphate-buffered osmium tetroxide for 30 min at room temperature and then washed two 139 
times for 10 min each with distilled water at room temperature. The cells were stained with 140 
2% aqueous saturated uranyl acetate for 15 min at room temperature. The cells were then 141 
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dehydrated in graded ethanol baths and embedded in resin. Ultrathin (95-100 nm) sections 142 
were post-stained with uranyl acetate and evaluated under TEM.  143 
2.10. Statistical analyses 144 
The data are expressed as the mean ± the S.E.M. Significance was assessed with one-145 
way analyses of variance (ANOVAs) followed by Tukey-Kramer tests using the scientific 146 
statistical software SPSS version 16. Probability (P) values below 0.05 were considered to 147 
indicate statistical significance. 148 
3. Results 149 
The effects of DEX treatment on ROS production were investigated in the SH-SY5Y 150 
cultured cells. The cells that were treated with 1 and 2 µM DEX for 90 min exhibited 151 
significant elevations of ROS production compared with the (0 µM DEX) control value (Fig. 152 
1A). The NADPH oxidase inhibitors 4-(2-aminoethyl) benzenesulfonyl fluoride 153 
hydrochloride (AEBSF, 20 μM) and diphenyleneiodonium (DPI, 0.5 μM), lipoxygenase 154 
inhibitor NDGA (10 μM) and xanthine oxidase inhibitor oxypurinol (10 μM) were applied to 155 
the cultured cells prior to treatment with DEX. AEBSF and DPI significantly diminished the 156 
DEX-induced increases in ROS production compared with the DEX-treated cells, 157 
respectively (Fig. 1B). The results demonstrated that exposure to 1 µM DEX for 24 hr 158 
significantly decreased the amount of GSH compared with the control-untreated cells (Fig. 159 
1C). The addition of 1 µM DEX significantly increased the rate of lipid peroxidation 160 
formation compared with the level observed in the control-untreated SH-SY5Y cells (Fig. 161 
1D). The viable cells were quantified with using propidium iodide (PI) staining (Fig. 1F). 162 
Treatment with 1.0 µM DEX for 24 hr significantly increased neuronal cell death compared 163 
with the control-untreated cells. Pretreatment with 0.25 mM melatonin significantly 164 
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decreased neuronal cell death compared with the DEX-treated cells without melatonin (Fig. 165 
1E). 166 
The applications of 1 µM DEX for 18 and 24 hr significantly increased [Ca2+]c compared 167 
with the levels observed in the DEX-treated cells at 0 hr (Fig. 2A). The cytosolic green 168 
fluorescence calcium staining signals were recorded in SH-SY5Y cells (Fig. 2B). Thus, 169 
treatment with 1 µM DEX for 24 hr significantly increased the cytosolic calcium level 170 
compared with the control value. Pretreatment with 0.25 mM melatonin was diminished this 171 
DEX-induced increase in cytosolic calcium. Melatonin alone had no effect on cytosolic 172 
calcium compared with the control-untreated cells (Fig. 2C). 173 
The effects of DEX-induced alterations of mitochondrial fission (Drp1 and Fis1) and 174 
mitochondrial fusion (Opa1 and Mfn1) proteins were determined in the SH-SY5Y cells using 175 
Western blot analyses. Treatment with 1.0 µM DEX for 24 hr significantly decreased the 176 
Drp1 expression compared with the control value. Additionally, treatments with 1.0 µM DEX 177 
for 1, 2, 12, 18 and 24 hr significantly decreased the amounts of Fis1 expression compared 178 
with the control value. Treatment with 1.0 µM DEX for 12 and 18 hr significantly increased 179 
the amount of Opa1 and Mfn1 compared with the control value, respectively (Fig. 3A). SH-180 
SY5Y cells were exposed to 1 µM DEX for the indicated times with or without pre-treatment 181 
with 0.25 mM melatonin for 1 hr (Fig. 3B-C). However, pretreatment of the SH-SY5Y cells 182 
with 0.25 mM melatonin for 1 hr prior to treatment with 1 µM DEX significantly increased 183 
the amounts of Drp1 and Fis1 (Fig. 3B) and significantly decreased the amounts of Opa1 and 184 
Mfn1(Fig. 3C) compared with the DEX-treated cells, respectively. Melatonin at 0.25 mM 185 
alone had no effect on the amounts of either the mitochondrial fission (Fig. 3B) or fusion 186 
(Fig. 3C) proteins in the SH-SY5Y cells compared to the control. 187 
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The protective effects of melatonin on DEX-induced alterations in mitochondrial 188 
morphology were examined using transmission electron microscopy (TEM). Control-189 
untreated cells exhibited both rod and elongate mitochondrial shapes. The matrix was fairly 190 
dark, and the cristae were regularly distributed (Fig. 4B arrows). The DEX-treated group 191 
exhibited electron-dense round, abnormal mitochondrial morphologies (Fig. 4D arrows) and a 192 
greater proportion elongated mitochondria shape (Fig. 4C arrows). Mitochondrial swelling, 193 
few remaining cristae and discontinuous outer membranes were also observed in the DEX-194 
treated cells (Fig. 4D arrowheads). Pretreatment with melatonin resulted in normal cristae 195 
structures and normal mitochondrial morphologies (Fig. 4E arrows).  196 
4. Discussion 197 
Long-term treatment with DEX has been proven to induce ROS production [9], and 198 
oxidative stress is recognized as a potent inducer of decreases in cell function and eventual 199 
cell death [10]. In the present study, toxically high doses of DEX were observed to induce 200 
increases in ROS formation in the dopaminergic SH-SY5Y cell line. Excessive production of 201 
ROS is the earliest sign of disturbed homeostasis that leads to neuronal cell death [11]. Two 202 
lines of evidence support the role of oxidative damage in DEX-induced toxicity in 203 
dopaminergic cells. First, it has been reported that DEX-treated murine neural stem cells 204 
exhibit decreased expressions of the antioxidant enzymes catalase and superoxide dismutase 205 
1 (SOD1), which results in the failures of antioxidant functions [12]. Second, DEX has been 206 
documented to increase monoamine oxidase (MAO) activity in SH-SY5Y cells [13] and in 207 
the rat substantia nigra [14], which leads to increases in intracellular dopamine oxidative 208 
deamination. Increases in ROS formation by DEX could, at least in part, be due to increases 209 
in dopamine oxidation by MAO [14]. It seems that DEX toxicity induces an imbalance that 210 
involves increased ROS production and reduced ROS scavenging. Taken together, our 211 
findings indicated that DEX-induced increases in ROS formation might be a part of a 212 
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mitochondria-dependent process as indicated by the ability of the NADPH-oxidase inhibitor 213 
(AEBSF and DPI) to reduce ROS formation. Excessive amounts of ROS induced oxidative 214 
damage to polyunsaturated fatty acids, which was observed as an increase in lipid 215 
peroxidation during DEX-induced toxicity. Supporting these hypotheses, reductions in 216 
antioxidant enzymes and glutathione levels or the induction of lipid peroxidation were 217 
demonstrated in the SH-SY5Y cultured cells. Similarly, considerable evidence suggests that 218 
glutathione depletion plays a major role in the progression toward cell death. Further 219 
induction of lipid peroxidation is produced by the breakdown of polyunsaturated fatty acids 220 
[15].  221 
The protective effects of melatonin and its metabolites have been demonstrated in a 222 
variety of oxidative stress-associated neuropathologies. Currently, it well documented that 223 
melatonin prevents the neurotoxin-induced deaths of hippocampal [16] and neuroblastoma 224 
cells [8]. Increasing amount of evidence support the neuroprotective effect of melatonin 225 
against calcium-dependent cell death cascades [17]. In the present study, we found that 226 
melatonin reversed the toxic insult of DEX in SH-SY5Y cells by decreasing cytotoxic 227 
calcium overload and cell death rates in dopaminergic SH-SY5Y cells. These results revealed 228 
the protective role of melatonin against DEX-induced oxidative stress and calcium-dependent 229 
death processes in SH-SY5Y cells. The present data corroborate those of previous studies in 230 
which melatonin was found to regulate intracellular processes, such as G-proteins, and the 231 
activities of second messengers, such as cAMP, IP3 and Ca2+ [18]. The Ca2+ signaling system 232 
modulates receptors and voltage-dependent calcium channels, pumps, exchangers and 233 
binding proteins [19]. Melatonin can prevent ischemic injury-induced reductions in the levels 234 
of the calcium-buffering proteins parvalbumin and hippocalcin in the cerebral cortical tissue 235 
of rats [17]. Recently, Espino et al. demonstrated the protective effect of melatonin 236 
supplementation against ER-stress-induced apoptosis driven by calcium signaling in human 237 
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leukocytes. It has been proposed that melatonin is able to delay calcium overload-induced 238 
apoptosis due to its antioxidant properties [20]. This postulated role of melatonin is consistent 239 
with evidence that has shown that ROS, such as H2O2, increase cytosolic calcium release 240 
from intracellular pools, which leads to apoptotic states [21].  241 
More importantly, we demonstrated that melatonin is able to diminish decreases in 242 
mitochondrial fission protein levels (Drp1 and Fis1) and increase mitochondrial fusion 243 
protein levels (Opa1 and Mfn1) in DEX-treated cells. Melatonin was able to prevent 244 
mitochondrial damage and preserve the mitochondrial membrane potential and energy 245 
production during cell stress [22]. We also examined the morphological alterations of the 246 
mitochondria with transmission electron microscopy. The DEX-treated cells exhibited 247 
numerous electron-dense, round, abnormal mitochondrial structures. Our data suggest that 248 
DEX play a critical role in activating ROS that are associated with mitochondrial fission-249 
fusion imbalances and cause progression to cell death. Excessive mitochondrial fusion seems 250 
to be important for DEX-induced neurotoxicity. Recent evidence has emphasized that 251 
excessive mitochondrial fusion and fission-fusion imbalances might lead to mitochondrial 252 
dysfunction [23]. It has been demonstrated that excessive fused mitochondria accumulate 253 
oxidative damage and further transform into large spheres. These large round mitochondria 254 
are associated with impaired function [24]. Our observations suggest that melatonin might 255 
exert its neuroprotective effects not only by inhibiting ROS generation but also by 256 
maintaining mitochondrial fission-fusion and cytosolic calcium homeostasis, which might 257 
reduce cell degeneration following DEX exposure.   258 
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Figure legends 334 
Fig. 1. (A-D) Effects of dexamethasone (DEX) on oxidative stress generation in SH-SY5Y 335 
cells. (A-B) ROS production, (C) Glutathione (GSH) and (D) lipid peroxidation were 336 
determined in SH-SY5Y cells. (E-F) The effects of melatonin (MEL) attenuate DEX-induced 337 
cell death in SH-SY5Y cells. (F) Propidium iodide (PI) fluorescence was used to detect the 338 
dead cells. The dead cells were counted and compared to the total numbers of cells present as 339 
identified by Hoechst 3342 nuclear staining. (E) The percentages of dead cells are presented 340 
in the graph. The values represent the means ± the S.E.M.s of four independent experiments. 341 
*P < 0.05, **P < 0.01 and ***P < 0.001 compared with the control-untreated cells, and #P < 342 
0.05 and ### P < 0.01 compared with the DEX-treated cells. 343 
Fig. 2. The effects of melatonin (MEL) on dexamethasone (DEX)-induced increases in 344 
cytosolic calcium levels in SH-SY5Y cells. (B) The fluo-4 stained cytosolic calcium is shown 345 
in green. (A and C) The changes in cytosolic calcium levels are presented in the graph. The 346 
results are expressed as the means ± the S.E.M.s of the three independent experiments. ***P 347 
< 0.001 compared with the DEX-treated cells at 0 hr, **P < 0.01 compared with the control 348 
and # P < 0.05 compared with the DEX-treated cells. 349 
Fig. 3. Effects of melatonin on dexamethasone (DEX)-induced alterations in fission (Drp1 350 
and Fis1) and fusion (Mfn1 and Opa1) protein levels. (A) The SH-SY5Y cells were treated 351 
with 1 µM DEX for 1-24 hr. Some cells were pre-treated with 0.25 mM melatonin (MEL) for 352 
1 hr prior to incubation with 1 µM DEX for another (C) 12 hr (Opa1), (C) 18 hr (Mfn1) or 353 
(B) 24 hr (Drp1 and Fis1) without changing the culture medium. The control-cultured cells 354 
were incubated with culture medium. The alterations in the fission and fusion protein levels 355 
were determined with Western blot analyses. Each protein bands was quantified by 356 
densitometry, and the differences are represented in the graph as the ratios of the fission and 357 
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fusion proteins to the β-actin bands. The values represent the means ± the S.E.M.s of four 358 
independent experiments. *P < 0.05, **P < 0.01 and ***P < 0.001 compared with the control 359 
and ##P < 0.01 compared with the DEX-treated cells. 360 
Fig. 4. The effects of melatonin on dexamethasone-induced morphological alterations of the 361 
mitochondria of the SH-SY5Y cells. The SH-SY5Y cells were treated with 1 µM 362 
dexamethasone for 24 hr (C-D). The control-untreated cells were incubated with culture 363 
medium for 24 hr (A-B). Some cells were treated with 1.0 µM dexamethasone for 24 hr with 364 
or without pretreatment with 0.25 mM melatonin for 1 hr (E-F). The mitochondrial 365 
morphologies were visualized under a transmission electron microscope. N = nucleus, Scale 366 
bars = 1.0 m and 500 nm. 367 
